Amgen, Inc. (AMGN)
403.04
-4.23
(-1.04%)
USD |
NASDAQ |
Oct 02, 16:00
403.83
+0.79
(+0.20%)
After-Hours: 20:00
Amgen Price : 403.04 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 410.16 | 410.16 | 401.96 | 403.04 | 3.510M |
| Oct 01, 2026 | 421.72 | 422.80 | 407.13 | 407.27 | 2.501M |
| Sep 30, 2026 | 424.01 | 426.59 | 420.63 | 421.51 | 3.131M |
| Sep 29, 2026 | 414.37 | 424.57 | 414.11 | 423.64 | 3.738M |
| Sep 28, 2026 | 411.52 | 419.02 | 410.96 | 418.13 | 2.918M |
| Sep 25, 2026 | 408.25 | 415.20 | 404.19 | 414.61 | 2.213M |
| Sep 24, 2026 | 406.09 | 409.99 | 403.88 | 406.04 | 2.525M |
| Sep 23, 2026 | 410.09 | 415.76 | 404.34 | 406.09 | 2.823M |
| Sep 22, 2026 | 405.25 | 413.00 | 398.52 | 410.24 | 3.721M |
| Sep 21, 2026 | 385.71 | 394.50 | 381.90 | 393.16 | 2.889M |
| Sep 18, 2026 | 378.51 | 386.50 | 378.51 | 385.65 | 8.528M |
| Sep 17, 2026 | 379.15 | 382.49 | 376.08 | 379.78 | 3.235M |
| Sep 16, 2026 | 377.01 | 379.11 | 374.46 | 376.35 | 2.402M |
| Sep 15, 2026 | 380.23 | 381.04 | 375.15 | 375.65 | 2.609M |
| Sep 14, 2026 | 381.94 | 384.61 | 376.76 | 381.50 | 2.715M |
| Sep 11, 2026 | 386.14 | 386.99 | 377.22 | 377.35 | 2.273M |
| Sep 10, 2026 | 387.84 | 391.67 | 381.51 | 382.47 | 3.432M |
| Sep 09, 2026 | 393.06 | 395.55 | 389.28 | 391.27 | 2.923M |
| Sep 08, 2026 | 408.90 | 410.02 | 391.17 | 393.17 | 6.832M |
| Sep 04, 2026 | 437.03 | 441.85 | 435.00 | 437.23 | 1.656M |
| Sep 03, 2026 | 445.67 | 445.82 | 438.08 | 444.12 | 1.842M |
| Sep 02, 2026 | 440.65 | 445.57 | 435.00 | 442.84 | 2.286M |
| Sep 01, 2026 | 435.30 | 438.65 | 431.00 | 438.12 | 2.359M |
| Aug 31, 2026 | 428.59 | 431.85 | 426.00 | 429.88 | 2.343M |
| Aug 28, 2026 | 437.89 | 437.89 | 430.72 | 432.42 | 1.740M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 144.74 |
| Regeneron Pharmaceuticals, Inc. | 735.20 |
| AbbVie, Inc. | 262.82 |
| Biogen, Inc. | 219.88 |
| Vertex Pharmaceuticals, Inc. | 504.73 |
Price Related Metrics
| PE Ratio | 25.04 |
| PS Ratio | 5.731 |
| PEG Ratio | 0.7897 |
| Price to Book Value | 18.64 |
| Price to Free Cash Flow | 21.52 |
| Earnings Yield | 3.99% |
| Market Cap | 217.88B |
| PEGY Ratio | 0.7327 |
| Operating PE Ratio | 17.21 |
| Normalized PE Ratio | 22.85 |